We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ketek Fallout May Be Just the Beginning of Drug Review Scrutiny
Ketek Fallout May Be Just the Beginning of Drug Review Scrutiny
December 29, 2006
The FDA may be facing increasing pressure from Capitol Hill due to its handling of Ketek, as a former agency official turned whistleblower is working with activists and a key Senate critic to take the FDA to task.